miR-146a regulates emphysema formation and abnormal inflammation in the lungs of two mouse models

Hitomi Yoshikawa1, Tadashi Sato1, Kimiko Horikoshi1

  • 1Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Insights

MicroRNA-146a (miR-146a) protects against emphysema and inflammation in mouse models. Loss of miR-146a exacerbates lung damage and inflammatory responses in chronic obstructive pulmonary disease (COPD) models.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Immunology

Background:

  • MicroRNA-146a (miR-146a) is implicated in inflammatory diseases.
  • In vitro studies suggest miR-146a's role in chronic obstructive pulmonary disease (COPD) pathogenesis.
  • In vivo evidence for miR-146a's role in COPD is limited.

Purpose of the Study:

  • To investigate the in vivo role of miR-146a in emphysema and associated inflammation.
  • To evaluate the protective effects of miR-146a in mouse models of COPD.

Main Methods:

  • Mice lacking miR-146a (miR-146a knockout) and wild-type mice were used.
  • Emphysema was induced via elastase administration or cigarette smoke (CS) exposure.
  • Lung structure, inflammation markers, and gene expression were analyzed.

Main Results:

  • miR-146a expression increased in wild-type mice lungs following elastase or CS exposure.
  • miR-146a knockout mice exhibited exacerbated emphysema and increased inflammatory responses.
  • Higher levels of inflammatory cells and mediators were observed in knockout mice.

Conclusions:

  • miR-146a plays a protective role against emphysema and inflammation in vivo.
  • Loss of miR-146a promotes emphysema development and exacerbates inflammatory responses.
  • This study provides the first in vivo evidence for miR-146a's protective role in emphysema.